SRRKMID

Scholar Rock Holding Corporation

HealthcareBiotechnology
$47.07
$0.00(-0.14%)
52W$27.07
$51.63
Updated May 7, 12:00 AM
RSI50
RS Rating77/99
Beta1.31
Volatility67%
F-Score1/9
Mkt Cap$5.4B
STAGE 2 UPTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

STAGE 2 UPTREND

Scholar Rock Holding Corporation is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is moderate (RS Rating: 77), indicating performance broadly in line with the market. Earnings contraction of 10% provides fundamental context to the price action. Investors should exercise caution due to high volatility (67% annualized), which requires wider risk management.

Relative Strength
77
out of 99
Average
Trend Score
4/4
Minervini Criteria
STAGE 2 UPTREND
Risk (Beta)
1.31
vs S&P 500
ABOVE MKT
52W Position
81%
from 52W low
Near High
Trend & Momentum Analysis

Trend Template (Minervini)

STAGE 2 UPTREND4/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$46.08
50 SMA > 100 SMA$45.69
100 SMA > 150 SMA$42.26
150 SMA > 200 SMA$40.24

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$47.88-1.70%BELOW
50 SMA$46.08+2.16%ABOVE
100 SMA$45.69+3.03%ABOVE
150 SMA$42.26+11.37%ABOVE
200 SMA$40.24+16.99%ABOVE

Price Performance

1D-0.1%
1W+1.7%
1M-3.6%
3M-1.2%
6M+63.4%
YTD+10.0%
1Y+60.6%
3Y+80.3%
52-Week Trading Range81% from low
$47.07
52W Low$27.07
52W High$51.63

Technical Indicators

RSI (14)NEUTRAL
50.3
305070
VCP ScoreWARM
7/10
Base depth: 27.4%

Risk Profile

Beta
1.31
52W Vol
67%
ATR
$1.63
Max DD (1Y)
-35%

Volume Analysis

Today
913.5K
50D Avg
1.54M
Vol Ratio
0.59x
Liquidity
LIQUID

Earnings Momentum

Q1'25-14%
$-0.67
Q2'25-63%
$-0.98
Q3'25-36%
$-0.90
Q4'25-10%
$-0.74
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:-30.56%

Stock Price CAGR

10 Years:+11.75%
5 Years:+9.73%
3 Years:+80.31%
1 Year:+60.59%

Return on Equity

10Y Avg:-84.5%
5Y Avg:-79.5%
3Y Avg:-91.4%
Last Year:-145.9%

Key Metrics

Market Cap$5.4B
Gross Margin
Net Margin
Piotroski F-Score1/9

Frequently Asked Questions

Is SRRK in an uptrend right now?

SRRK has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, SRRK is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.

Is SRRK overbought or oversold?

SRRK's RSI (14) is 50. The stock is in neutral territory, neither overbought nor oversold.

Is SRRK outperforming the market?

SRRK has a Relative Strength (RS) Rating of 77 out of 99. SRRK is performing about average compared to the market.

Where is SRRK in its 52-week range?

SRRK is trading at $47.07, which is 91% of its 52-week high ($51.63) and 81% above its 52-week low ($27.07).

How volatile is SRRK?

SRRK has a Beta of 1.31 and 52-week volatility of 67%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.